晚期烟酸酸酶缺陷细胞癌对组合免疫检查点抑制剂有反应
Erin Howells1, Lucas Wigston2, Gavin Mackie1
1Royal Hobart Hospital, Tasmania, Australia.
The Canadian journal of urology
|June 21, 2023
概括
富马酸酸酶缺陷细胞癌 (FHdef RCC) 是一种攻击性细胞癌. 与伊皮利穆马布和尼沃卢马布的联合免疫疗法在三例转移性FHdef RCC病例中显示出瘤反应.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 酸酸酶缺乏性细胞癌 (FHdef RCC) 是一种罕见且具有攻击性的癌亚型.
- 它经常与遗传性线性肌肉瘤和细胞癌 (HLRCC) 综合征有关,源于烟酸酸酶 (FH) 基因突变.
- 关于高级FHdef RCC有效的全身治疗方法的数据有限.
研究的目的:
- 评估结合免疫疗法在患有晚期FHdef RCC的患者中的疗效.
- 为了呈现FHdefRCC的临床病例,用ipilimumab和nivolumab治疗.
主要方法:
- 对三例转移性FHdefRCC病例的回顾性审查.
- 使用联合伊皮利穆马布和尼沃卢马布 (Ipi/Nivo) 的治疗.
- 临床特征,诊断和医学成像分析.
主要成果:
- 这三名患者 (男性50岁,男性27岁,女性48岁) 均实现了瘤反应.
- 组合免疫疗法在转移性FHdef RCC中显示出有效性.
结论:
- 结合伊皮利穆马布和尼沃卢马布是一种有前途的治疗选择,用于晚期FHdef RCC.
- 需要进一步的研究,以在更大的队列中证实这些发现.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.9K
09:54Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
Published on: May 22, 2020
3.6K
相关概念视频
01:27Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
02:50Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K